Cargando…
Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113078/ https://www.ncbi.nlm.nih.gov/pubmed/37082659 http://dx.doi.org/10.21037/atm-2022-78 |
| _version_ | 1785027747468279808 |
|---|---|
| author | Rutkowski, Piotr Czarnecka, Anna M. |
| author_facet | Rutkowski, Piotr Czarnecka, Anna M. |
| author_sort | Rutkowski, Piotr |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10113078 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101130782023-04-19 Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases Rutkowski, Piotr Czarnecka, Anna M. Ann Transl Med Editorial Commentary AME Publishing Company 2023-01-16 2023-03-31 /pmc/articles/PMC10113078/ /pubmed/37082659 http://dx.doi.org/10.21037/atm-2022-78 Text en 2023 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary Rutkowski, Piotr Czarnecka, Anna M. Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases |
| title | Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases |
| title_full | Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases |
| title_fullStr | Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases |
| title_full_unstemmed | Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases |
| title_short | Triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases |
| title_sort | triple combinations of immunotherapy and targeted therapy in patients with melanoma with brain metastases |
| topic | Editorial Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113078/ https://www.ncbi.nlm.nih.gov/pubmed/37082659 http://dx.doi.org/10.21037/atm-2022-78 |
| work_keys_str_mv | AT rutkowskipiotr triplecombinationsofimmunotherapyandtargetedtherapyinpatientswithmelanomawithbrainmetastases AT czarneckaannam triplecombinationsofimmunotherapyandtargetedtherapyinpatientswithmelanomawithbrainmetastases |